Search results for "Prostate Cancer"
Docetaxel may prolong prostate cancer survival in patients with metastasis
Docetaxel added to the start of hormone therapy for metastatic prostate cancer may prolong survival compared to patients who received hormone therapy alone, according to early results from a trial.
https://immattersacp.org/weekly/archives/2013/12/17/4.htm
17 Dec 2013
Prostate cancer treatment options result in similar 15-year outcomes
Functional outcomes among men undergoing prostatectomy or radiotherapy for prostate cancer differed at two and five years of follow-up, but significant differences were no longer present by 15 years, a study found.
https://immattersacp.org/weekly/archives/2013/02/05/4.htm
5 Feb 2013
New guidance urges caution on testosterone
Internists considering testosterone therapy are ideally positioned to consider a broader differential diagnosis that will actually help the patient.
https://immattersacp.org/archives/2020/05/new-guidance-urges-caution-on-testosterone.htm
1 May 2020
Internists should follow up with prostate cancer patients receiving ADT
Some H1N1 vaccine to expire next week Didanosine gets labeling change Hemodialysis system recalled
https://immattersacp.org/weekly/archives/2010/02/09/5.htm
9 Feb 2010
Model predicts erectile function after prostate cancer
Researchers have developed a new model to predict the risk of erectile dysfunction for men undergoing prostate cancer treatment.
https://immattersacp.org/weekly/archives/2011/09/27/4.htm
27 Sep 2011
Losing it: A rational approach to hair loss
Fun facts about the hair cycle, five questions about the condition, and treatment options can help internists address an emotional topic for patients.
https://immattersacp.org/archives/2019/06/losing-it-a-rational-approach-to-hair-loss.htm
1 Jun 2019
Little difference found among prostate cancer treatments regarding clinical results, patient-reported outcomes
More men in the active-monitoring group developed metastases than in the surgery or radiotherapy groups, and there were higher rates of disease progression in the active-monitoring group than in the surgery or radiotherapy groups.
https://immattersacp.org/weekly/archives/2016/09/20/2.htm
20 Sep 2016
Squeezing in the cancer screening talk
By making the most of team members and technology, internists can free up valuable physician-patient interaction time to most effectively apply cancer screening guidelines.
https://immattersacp.org/archives/2019/10/squeezing-in-the-cancer-screening-talk.htm
1 Oct 2019
European study finds prostate cancer mortality reduced by PSA screening
Prostate-specific antigen (PSA)-based screening significantly reduced mortality from prostate cancer but did not affect all-cause mortality, according to two more years of follow-up results in the European Randomized Study of Screening for Prostate Cancer.
https://immattersacp.org/weekly/archives/2012/03/20/4.htm
20 Mar 2012
More patients undergoing active surveillance for lower-risk prostate cancers
Use of active surveillance or watchful waiting for prostate cancer rose from 2010 to 2018, although uptake was lower in men with multiple positive biopsy cores and those who were Asian/Pacific Islander and Hispanic, had a lower income, or lived in a rural area.
https://immattersacp.org/weekly/archives/2023/04/11/4.htm
11 Apr 2023